Blog
RSS FeedPosted by Michael Wonder on 10 Aug 2020
Return some excess drug revenues to employers, CLHIA says in submission to PMPRB
10 August 2020 - In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and ...
Posted by Michael Wonder on 04 Aug 2020
Innovative Medicines Canada responds to the revised draft PMPRB Guidelines consultation
4 August 2020 - The Patented Medicine Prices Review Board's revised Guidelines will result in patients losing access to innovative ...
Posted by Michael Wonder on 14 Jul 2020
PMPRB changes within scope of Patent Act, rules federal court in judicial review
13 July 2020 - The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the ...
Posted by Michael Wonder on 29 Jun 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...
Posted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 01 Jun 2020
Canada's new drug price rules pushed to next year
1 June 2020 - Canada's drug pricing agency said on Monday that new regulations aimed at lowering costs would come ...
Posted by Michael Wonder on 26 May 2020
B.C. mom’s drug pricing petition on behalf of son garners thousands of signatures
26 May 2020 - Petition geared to gaining access to new medicines drew support of Chilliwack-Hope MP Mark Strahl. ...
Posted by Michael Wonder on 21 May 2020
Canada grapples with drug price escalation
20 May 2020 - In July 2020 Canada will implement a series of reforms to help bring runaway drug prices under ...
Posted by Michael Wonder on 03 May 2020
Canadian prescription drug prices come under scrutiny of U.S. trade representative
1 May 2020 - The United States is keeping Canada and its plans to overhaul its drug-pricing system on a ...
Posted by Michael Wonder on 24 Feb 2020
Alberta’s switch to biosimilar drugs may pose legal challenges for doctors
24 February 2020 - Prescribing cheaper medications for arthritis, diabetes or Crohn’s disease could be at odds with physicians’ legal requirement ...
Posted by Michael Wonder on 20 Feb 2020
Canadian regulator considers changes to new drug pricing plan
20 February 2020 - Canada’s drug pricing agency is contemplating significant changes to how it will apply new regulations aimed at ...
Posted by Michael Wonder on 09 Feb 2020
Extreme regulations to lower drug prices mean Canada will get fewer new drugs
7 February 2020 - Severe price cuts would clearly discourage pharmaceutical manufacturers from launching new drugs in Canada. ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 02 Dec 2019
Premiers want Ottawa to allow opt out for proposed Pharmacare plan
2 December 2019 - Canada's premiers say they want the federal government to increase health-care transfer funds by just over ...
Posted by Michael Wonder on 25 Nov 2019
Proposed Ontario drug regulation changes worry policy experts
22 November 2019 - The Ontario government is proposing drug regulation changes that it says will remove red tape and ...